Stay updated on Losartan and Nivolumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page
- Check5 days agoChange DetectedSite revision updated from v3.6.0 to v3.6.2, reflecting a backend platform update on the study page. No study details or navigation are affected.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedDifference0.4%

- Check26 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, signaling a minor update to the page's build or content management system. This update does not modify the study details, eligibility criteria, or results presented on the page.SummaryDifference0.0%

- Check48 days agoChange DetectedA revision label was updated from v3.5.3 to v3.5.4. This indicates a minor update to the page's versioning or metadata rather than substantive content changes.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page’s revision/version label has been updated from v3.5.2 to v3.5.3, reflecting a release of the website interface rather than a modification to the clinical trial record.SummaryDifference0.0%

- Check76 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Losartan and Nivolumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.